Graphic representation of a human lung with technical elements and the logo ‘eFlow Technology’ in the background.

Focus on Your Breakthrough

We Ensure Reliable Drug Delivery

Bringing new innovative inhalation therapies to market is a long and risky process. The interaction of drug and device involves a high degree of complexity where both technical and regulatory requirements must be met. Having this in mind, choosing the ideal nebulizer and device partner can make all the difference and reduce overall development risks.

Focus on your formulation, knowing a reliable partner takes care of the device and supports you through the development.  


Rely on PARI as a trusted partner for the most suitable nebulizer - ensuring the best fit to your drug.

Schematic illustration showing the combination of a drug formulation with an eFlow Technology mesh nebulizer for targeted aerosol delivery to the lungs.

Proven Expertise You Can Rely On

Timeline of drug approvals using eFlow Technology across multiple regions.

Why PARI is Your Trusted Partner

  • Proven Expertise: 20+ years of experience and a strong track record in mesh nebulizer technology
  • High-End Mesh Technology: eFlow Technology defines the state-of-the-art in performance
  • Highest Flexibility: A broad platform concept for the most efficient and adaptable nebulizers
  • End-to-End Support: In-house aerosol services, regulatory and usability expertise for rapid customization
  • Reliable Supply: High-quality manufacturing at two PARI sites for clinical and commercial success

    

"We take clinical risk but don’t want to add device risks. That’s why we like it when our portfolio-companies use eFlow."

Investor (during ATS 2024 podium discussion)

  

"When I mention that we work with PARI all discussions on device risk at Wallstreet are over." 

CEO (during ERS 2024)

   

Ongoing Disclosed Projects – Your Success Could Be Next

Ongoing Disclosed Projects

More than 20 undisclosed projects in pre-clinical and 
clinical development with various drug classes

40% 
Biologics

20%
Nucleotides

40%
Small molecules

Need More Details Before Reaching Out?

Discover how PARI supports you in achieving impactful clinical results and commercial success

   
     
   
           

Let`s partner for success!

eFlow-partneringpari.com

Two smiling men in a blue circle. The central man wears glasses and a light blue shirt. The man on the left has a beard and a blue patterned shirt.

PARI Business Development Team